Exploring the effects of mavacamten through hemodynamic force analysis in patients with obstructive hypertrophic cardiomyopathy
Event:
ESC Congress 2024
Topic:
Pharmacotherapy
Session:
Cardiac myosin inhibitors for treatment of hypertrophic obstructive cardiomyopathy
